日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hormones and Nephrons: Disentangling the Thyroid-Kidney Connection

激素与肾单位:揭开甲状腺与肾脏的联系

Rhee, Connie M; Narasaki, Yoko

Leptin and Adiponectin as Uremic Adipokines: Associations with Survival in a Prospective Hemodialysis Cohort

瘦素和脂联素作为尿毒症脂肪因子:与前瞻性血液透析队列研究生存率的相关性

Bui, Thuy-Anh V; You, Amy S; Kalantar, Sara S; Yoon, Jihoon; Narasaki, Yoko; Sy, John; Hanna, Ramy; Daza, Andrea; Guerrero, Yalitzi; Dang, Anyssa; Arora, Ria; Nguyen, Danh V; Kalantar-Zadeh, Kamyar; Rhee, Connie M

Sleep Patterns, Symptoms, and Mortality in Hemodialysis: A Prospective Cohort Study

血液透析患者的睡眠模式、症状和死亡率:一项前瞻性队列研究

Narasaki, Yoko; You, Amy S; Kurtz, Ira; Nobakht, Niloofar; Kamgar, Mohammad; Siu, Man Kit Michael; Ahdoot, Rebecca S; Hanna, Ramy; Kalantar, Sara S; Yoon, Jihoon; Le, Lisa; Torres Rivera, Silvina; Nakata, Tracy; Arora, Ria; Nguyen, Danh V; Kalantar-Zadeh, Kamyar; Rhee, Connie M

Genetic Panel Testing for Malignant Hyperthermia in Japan: Discovery of Novel Variants and Clinical Implications

日本恶性高热基因检测:新变异的发现及其临床意义

Miyoshi, Hirotsugu; Mukaida, Keiko; Otsuki, Sachiko; Kido, Kenshiro; Sumii, Ayako; Ikeda, Tsuyoshi; Xia, Guoqiang; Noda, Yuko; Ishii, Tomomi; Kamiya, Satoshi; Narasaki, Soshi; Niinai, Hiroshi; Tsutsumi, Yasuo M

Comparison between single bolus dose administration and continuous infusion of remimazolam for general anesthesia induction in non-cardiac surgery: a single-center prospective randomized controlled trial

比较单次推注与持续输注瑞米唑仑用于非心脏手术全身麻醉诱导的效果:一项单中心前瞻性随机对照试验

Ikeda, Tsuyoshi; Miyoshi, Hirotsugu; Kido, Kenshiro; Sumii, Ayako; Otsuki, Sachiko; Kato, Takahiro; Nakamura, Ryuji; Narasaki, Soshi; Tsutsumi, Yasuo M

Comparison of AceScope With Tube-Channelled Blade Versus McGRATH MAC Video Laryngoscope With Non-channelled Blade in a Difficult-Airway Manikin Model

在困难气道模型中比较带管状通道刀片的AceScope喉镜与带非通道刀片的McGRATH MAC视频喉镜

Ishii, Tomomi; Kondo, Takashi; Otsuki, Sachiko; Ota, Yuki; Narasaki, Soshi; Toyota, Yukari; Saeki, Noboru; Tsutsumi, Yasuo M

Should a low-protein diet and ketoanalogue supplementation be part of the management of advanced chronic kidney disease?

低蛋白饮食和酮类物质补充是否应纳入晚期慢性肾病的治疗方案中?

Narasaki, Yoko; Jo, Hyung-Ah; Rhee, Connie M

Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study

SGLT2抑制剂、DPP-4抑制剂和GLP-1受体激动剂在美国患有和未患有慢性肾脏病的退伍军人中的安全性:一项基于人群的研究

Narasaki, Yoko; Kovesdy, Csaba P; You, Amy S; Sumida, Keiichi; Mallisetty, Yamini; Surbhi, Satya; Thomas, Fridtjof; Amin, Alpesh N; Streja, Elani; Kalantar-Zadeh, Kamyar; Rhee, Connie M

Impact of Thyroid Status on Incident Kidney Dysfunction and Chronic Kidney Disease Progression in a Nationally Representative Cohort

甲状腺状态对全国代表性队列中新发肾功能障碍和慢性肾脏病进展的影响

You, Amy S; Kalantar-Zadeh, Kamyar; Brent, Gregory A; Narasaki, Yoko; Daza, Andrea; Sim, John J; Kovesdy, Csaba P; Nguyen, Danh V; Rhee, Connie M

Racial Disparities in End-Stage Kidney Disease Outcomes among Asians and Native Hawaiians and Other Pacific Islanders across Geographic Residence

亚裔、夏威夷原住民和其他太平洋岛民在不同地理居住地的终末期肾病预后方面存在种族差异

You, Amy S; Norris, Keith C; Kataoka-Yahiro, Merle; Davis, James; Page, Victoria; Hayashida, Glen; Narasaki, Yoko; Cheng, Shiuh Feng; Ng, Roland; Wong, Linda L; Lee, Lung-Yi; Kalantar-Zadeh, Kamyar; Rhee, Connie M